| P50 | author | Luis Eduardo Calliari | Q60325238 |
| | Osmar Monte | Q79423810 |
| P2093 | author name string | Neiva Damaceno | |
| | Renata Maria de Noronha | |
| | Lucia Harumi Muramatu | |
| P2860 | cites work | Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality | Q22255438 |
| | Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA | Q28119124 |
| | Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis | Q30662248 |
| | Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications | Q33264765 |
| | Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report | Q33739945 |
| | Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review | Q34351912 |
| | Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society | Q34351928 |
| | Clinical importance of cystic fibrosis-related diabetes | Q36033722 |
| | Diabetes: a major co-morbidity of cystic fibrosis. | Q36248884 |
| | Microvascular complications in cystic fibrosis-related diabetes. | Q36745248 |
| | Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. | Q36842031 |
| | Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes | Q36885591 |
| | Glucose tolerance in patients with cystic fibrosis: five year prospective study | Q36905808 |
| | Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review | Q37149541 |
| | Management of cystic fibrosis-related diabetes | Q37259700 |
| | Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1 | Q37319146 |
| | Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial | Q37364992 |
| | Oral glucose tolerance testing in children with cystic fibrosis | Q37377703 |
| | Management of cystic fibrosis-related diabetes in children and adolescents | Q37597457 |
| | Cystic fibrosis-related diabetes in childhood | Q37700083 |
| | Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline | Q40747884 |
| | Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes | Q43748972 |
| | Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis | Q43759573 |
| | Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents | Q43763355 |
| | Cystic fibrosis-related diabetes: a frequent co-morbidity | Q43957797 |
| | Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia | Q44490291 |
| | One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. | Q46126609 |
| | Use of the insulin pump in treat cystic fibrosis related diabetes | Q46151372 |
| | No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes | Q46315068 |
| | Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). | Q46488650 |
| | Calpain 10 and development of diabetes mellitus in cystic fibrosis | Q46867838 |
| | A teenage girl with cystic fibrosis-related diabetes, diabetic ketoacidosis, and cerebral edema | Q48935663 |
| | Cystic fibrosis related diabetes in an extremely young patient. | Q51107022 |
| | Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. | Q51522306 |
| | Abnormal lipid concentrations in cystic fibrosis. | Q51542736 |
| | Pancreatic endocrine function in cystic fibrosis. | Q51610960 |
| | Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. | Q54095932 |
| | Diabetes mellitus in cystic fibrosis: genetic and immunological markers. | Q54249246 |
| | Cystic fibrosis at a Brazilian center of excellence: clinical and laboratory characteristics of 104 patients and their association with genotype and disease severity | Q61764131 |
| | Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis | Q62130798 |
| | Diabetes mellitus associated with cystic fibrosis | Q68276767 |
| | Correlation between genotype and phenotype in patients with cystic fibrosis | Q72383694 |
| | DNA analysis of cystic fibrosis in Brazil by direct PCR amplification from Guthrie cards | Q72906776 |
| | [Study of the frequency of diabetes mellitus and glucose intolerance in patients with cystic fibrosis] | Q79334132 |
| | Infancy-onset cystic fibrosis-related diabetes | Q81266232 |
| | Epidemiology of cystic fibrosis-related diabetes | Q81713930 |
| | Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance | Q83305414 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 613-621 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Arquivos Brasileiros de Endocrinologia e Metabologia | Q15751181 |
| P1476 | title | Update on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD) | |
| P478 | volume | 55 | |